Comparing cancer treatment in the United States and Europe reveals significant differences in approach . The US system, often characterized as fee-for-service , tends to focus cutting-edge technologies , frequently resulting in higher costs and inconsistent access for care. Conversely, many European systems operate under socialized medicine models,